KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients

January 6, 2015

Source: Humanigen, Inc.

Released January 6, 2015

©2019 Humanigen, Inc.  All rights reserved